These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17373976)

  • 1. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of self-reported nail counts in patients with onychomycosis: A retrospective pilot analysis.
    Cham PM; Chen SC; Grill JP; Warshaw EM
    J Am Acad Dermatol; 2008 Jan; 58(1):136-41. PubMed ID: 17964690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001.
    Ioannidou DJ; Maraki S; Krasagakis SK; Tosca A; Tselentis Y
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):170-4. PubMed ID: 16441625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients.
    Szepietowski JC; Reich A; Garlowska E; Kulig M; Baran E;
    Arch Dermatol; 2006 Oct; 142(10):1279-84. PubMed ID: 17043182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Shemer A; Nathansohn N; Kaplan B; Trau H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients.
    Gupta AK; Jain HC; Lynde CW; Macdonald P; Cooper EA; Summerbell RC
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):244-8. PubMed ID: 10906646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of mycological investigations in diagnostics of nail changes.
    Maleszka R; Ratajczak-Stefańska V; Mikulska D
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():36-8. PubMed ID: 16119622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of toenail onychomycosis on patient quality of life.
    Elewski BE
    Int J Dermatol; 1997 Oct; 36(10):754-6. PubMed ID: 9372349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
    Aman S; Akbar TM; Hussain I; Jahangir M; Haroon TS
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):618-20. PubMed ID: 14700485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achilles foot screening project: preliminary results of patients screened by dermatologists.
    Roseeuw D
    J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S6-9; discussion S17. PubMed ID: 10509935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of onychomycosis on quality of life.
    Whittam LR; Hay RJ
    Clin Exp Dermatol; 1997 Mar; 22(2):87-9. PubMed ID: 9330072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onychomycosis: rationalization of topical treatment.
    Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
    Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis.
    Firooz A; Khamesipour A; Dowlati Y
    J Dermatolog Treat; 2003 Jun; 14(2):95-8. PubMed ID: 12775316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.
    Drake LA; Patrick DL; Fleckman P; Andr J; Baran R; Haneke E; Sapède C; Tosti A
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):189-96. PubMed ID: 10426887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to improve efficacy of onychomycosis treatment?].
    Nowicki R
    Wiad Parazytol; 2001; 47(4):823-32. PubMed ID: 16886434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.